Reform history

Commission Implementing Regulation (EU) 2021/52 of 22 January 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (Text with EEA relevance)

1 version · 2021-01-22
2026-04-15
Commission Implementing Regulation (EU) 2021/52 of 22 January 2021 a
original version Text at this date